Cargando…
Dual therapy for Aβ amyloidosis in AD: A successful one-two combo
In this issue, Chiang et al. (https://doi.org/10.1084/jem.20171484) make a notable contribution to Alzheimer disease (AD) therapeutics in a thorough and rigorous study demonstrating superior efficacy of dual therapy against Aβ in a mouse model of amyloid β deposition.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Rockefeller University Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940274/ https://www.ncbi.nlm.nih.gov/pubmed/29685951 http://dx.doi.org/10.1084/jem.20180494 |
| _version_ | 1783321086679580672 |
|---|---|
| author | Patel, Tirth K. Holtzman, David M. |
| author_facet | Patel, Tirth K. Holtzman, David M. |
| author_sort | Patel, Tirth K. |
| collection | PubMed |
| description | In this issue, Chiang et al. (https://doi.org/10.1084/jem.20171484) make a notable contribution to Alzheimer disease (AD) therapeutics in a thorough and rigorous study demonstrating superior efficacy of dual therapy against Aβ in a mouse model of amyloid β deposition. |
| format | Online Article Text |
| id | pubmed-5940274 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Rockefeller University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-59402742018-11-07 Dual therapy for Aβ amyloidosis in AD: A successful one-two combo Patel, Tirth K. Holtzman, David M. J Exp Med News In this issue, Chiang et al. (https://doi.org/10.1084/jem.20171484) make a notable contribution to Alzheimer disease (AD) therapeutics in a thorough and rigorous study demonstrating superior efficacy of dual therapy against Aβ in a mouse model of amyloid β deposition. Rockefeller University Press 2018-05-07 /pmc/articles/PMC5940274/ /pubmed/29685951 http://dx.doi.org/10.1084/jem.20180494 Text en © 2018 Patel and Holtzman http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
| spellingShingle | News Patel, Tirth K. Holtzman, David M. Dual therapy for Aβ amyloidosis in AD: A successful one-two combo |
| title | Dual therapy for Aβ amyloidosis in AD: A successful one-two combo |
| title_full | Dual therapy for Aβ amyloidosis in AD: A successful one-two combo |
| title_fullStr | Dual therapy for Aβ amyloidosis in AD: A successful one-two combo |
| title_full_unstemmed | Dual therapy for Aβ amyloidosis in AD: A successful one-two combo |
| title_short | Dual therapy for Aβ amyloidosis in AD: A successful one-two combo |
| title_sort | dual therapy for aβ amyloidosis in ad: a successful one-two combo |
| topic | News |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940274/ https://www.ncbi.nlm.nih.gov/pubmed/29685951 http://dx.doi.org/10.1084/jem.20180494 |
| work_keys_str_mv | AT pateltirthk dualtherapyforabamyloidosisinadasuccessfulonetwocombo AT holtzmandavidm dualtherapyforabamyloidosisinadasuccessfulonetwocombo |